Overall (n = 74)

Younger group (n = 42)

Elderly group (n = 32)

p value

Chemotherapy

Adjuvant

44

31

13

0.0094

Recurrence

25

10

15

Intensive, Induction

5

1

4

Regimen

GEM + CBDCA

44

27

17

0.3333

PTX + CBDCA

30

15

15

Planned cycles

1/2/3/4/5/6 cycles

3/33/8/23/0/7

3/19/5/13/0/2

0/14/3/10/0/5

0.3230

Received cycles

1/2/3/4/5/6 cycles

4/33/9/21/1/6

3/19/6/12/0/2

1/14/3/9/1/4

0.6133

Compliance

Completed

71(95.9%)

41(97.6%)

30(93.8%)

0.2304

Discontinued

2(2.7%)

0(2.4%)

2^*(6.3%)

Dose reduction

8(10.8%)

5(11.9%)

3(9.4%)

Delayed

3(4.1%)

3(7.1%)

0(0.0%)

Response to treatment (RECIST)

Partial response (PR)

11

2

9

0.1100

(n = 30)

Stable disease (SD)

19

9

10

Toxicities

≥Grade 3/4

43(58.1%)

23(54.8%)

20(62.5%)

0.5040